Clough Global Equity Fund director buys 260 shares

No Rule 10b5-1 trading plan is reported for director John E. Kowaleski's purchase.

Available on EDGAR 11/04/2026 - 11:51 AM EST Accepted by SEC EDGAR 11/04/2026 - 11:50 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Clough Global Equity Fund director John E. Kowaleski purchased 260 common shares of beneficial interest on November 3, 2026, at $7.56 per share. The transaction is reported as a direct, non-derivative purchase, and his reported direct holdings afterward were 260 shares. The transaction description identifies it as a purchase in an open market or private transaction.

Insider Trade Summary

Net Buyer: 260 shares

Net Buy 1 txn

Insider Kowaleski John E.

Role Director

Bought 260 shs ($2K)

Type	Security	Shares	Price	Value
Purchase	Common shares of beneficial interest	260	$7.56	$2K

Holdings After Transaction: Common shares of beneficial interest — 260 shares (Direct)

Key Figures

Shares purchased: 260 shares Purchase price: $7.56 per share Direct holdings after transaction: 260 shares

3 metrics

Shares purchased 260 shares November 3, 2026

Purchase price $7.56 per share November 3, 2026

Direct holdings after transaction 260 shares Following the November 3, 2026 purchase

Key Terms

shares of beneficial interest

1 terms

shares of beneficial interest financial

"common shares of beneficial interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GLQ shares did director John E. Kowaleski buy?

John E. Kowaleski purchased 260 Clough Global Equity Fund common shares of beneficial interest on November 3, 2026, at $7.56 per share. His reported direct holdings afterward were 260 shares. No Rule 10b5-1 plan is reported for the purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kowaleski John E.

(Last) (First) (Middle)

53 STATE STREET, 27TH FLOOR

(Street)

BOSTON MASSACHUSETTS 02109

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clough Global Equity Fund [ GLQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common shares of beneficial interest	11/03/2026		P		260	A	$7.56	260	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/S/ John E. Kowaleski	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)